Candel Therapeutics, Inc. (CADL) Social Stream
CANDEL THERAPEUTICS INC (CADL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CADL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 2 | $22 | $9 | $15.5 | $1.41 | 999.29% |
| 2021-11-19 | 3 | $22 | $9 | $16.333 | $1.41 | 1058.37% |
| 2022-06-15 | 1 | $22 | $12 | $17 | $1.41 | 1105.67% |
| 2022-12-02 | 2 | $22 | $11 | $15 | $1.41 | 963.83% |
| 2023-05-22 | 3 | $11 | $3 | $7 | $1.41 | 396.45% |
| 2023-11-13 | 2 | $11 | $3 | $7 | $1.41 | 396.45% |
Price Target Last Issued June 15, 2022
The Trend in the Analyst Price Target
CADL's average price target has moved down $8.5 over the prior 27 months.
CADL reports an average of 589.13% for its upside potential over the past 175 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-22 | 2 | 22 | 11 | 16.5 | 1.69 | 876.33% |
| 2023-05-22 | 3 | 22 | 3 | 12.0 | 1.69 | 610.06% |
| 2023-05-22 | 3 | 11 | 3 | 7.0 | 1.69 | 314.2% |
| 2023-05-22 | 3 | 22 | 11 | 16.5 | 1.69 | 876.33% |
| 2023-08-24 | 2 | 11 | 3 | 7.0 | 1.29 | 442.64% |
CADL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 18 months, CADL's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, CANDEL THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1254.51% of them.
- In the context of all US stocks, CANDEL THERAPEUTICS INC's number of analysts covering the stock is higher than 65.81% of them.
- CADL has a lower variance in analysts' estimates than -889.03% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of Healthcare stocks, CANDEL THERAPEUTICS INC's average analyst price target is greater than 330.24% of them.
Stocks similar to CANDEL THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TNYA, AURA, and CMPX.
View All Top Stocks by Price Target
Make investment decisions regarding CADL using the data that counts. Try POWR Ratings for free.